natgillin/translations-raw huggingface dataset:
Pneumonia, Upper respiratory tract infection, Bacterial, viral and fungal infections (including opportunistic infections), Nasopharyngitis, Pharyngitis, Bronchitis
pljučnica, okužbe zgornjih dihal, bakterijske, virusne in glivične okužbe (vključno z oportunističnimi okužbami), nazofaringitis, faringitis, bronhitis
Pneumonia.
pljučnica
pneumonia1
pljučnica1
pneumoniaa, bronchitis
pljučnicaa, bronhitis
pneumoniaa, upper respiratory tract infection
pljučnicaa, okužba zgornjih dihal
Pneumoniab
pljučnicab
Pneumoniac
pljučnic ac
Pneumonia§, sepsis
bakterijska okužba pljučnica§, sepsa
pneumonis (infection of the lungs)
pljučnica (okužba pljuč);
Pneumonitis
Bolezni sečil
Pneumonitis
Neznano
pneumonitis
plevralna efuzija1)
Pneumonitis
pljučnica
Pneumonitis
pnevmonitis
pneumonitis
pnevmonitis,
Pneumonitis (ILD)
pnevmonitis (intersticijska bolezen pljuč)
pneumonitis (interstitial lung disease)
pnevmonitis (intersticijska bolezen pljuč)
Pneumonitis allergic
alergijski pnevmonitis
Pneumonitis c, epistaxis, cough
pljučnicac, krvavitev iz nosu, kašelj
Pneumonitis has been reported in a small number of patients receiving olaparib, and some reports have been fatal.
Pri majhnem številu bolnic, ki so prejemale olaparib, so poročali o pnevmonitisu, v nekaterih primerih tudi s smrtnim izidom.
Pneumonitis led to discontinuation of pembrolizumab in 36 (1.3%) patients.
Pnevmonitis je povzročil ukinitev zdravljenja s pembrolizumabom pri 36 bolnikih (1,3 %).
Pneumonitis resolved in 55 patients.
Izzvenel je pri 55 bolnikih.
pneumonitis,
intersticijski
pneumonitis,
pnevmonitis,
pneumonitis, dyspnoea, cough
pljučnica, dispneja, kašelj
Pneumonitis, including fatal cases, has been reported in patients receiving pembrolizumab (see section 4.8).
Pri bolnikih, ki so prejemali pembrolizumab, so poročali o pnevmonitisu, vključno s smrtnimi primeri (glejte poglavje 4.8).
pneumonitisa,b, dyspnoea, cough
pnevmonitisa,b, dispneja, kašelj
pneumonitisa,b, pulmonary embolisma, dyspnoea, cough
pnevmonitisa,b, pljučna embolijaa, dispneja, kašelj
pneumonitisf, dyspnea, cough
pnevmonitisf, dispneja, kašelj
Pneumothorax,
pnevmotoraks,
PNH and aHUS patients under 18 years old receive lower doses based on their body weight, administered over 1 to 4 hours.
Bolnikom z obema boleznima, mlajšim od 18 let, se glede na njihovo telesno maso dajejo nižji odmerki, in sicer v trajanju od ene do štirih ur.
PNH patients receiving Soliris therapy should be similarly monitored for intravascular haemolysis by measuring LDH levels, and may require dose adjustment within the recommended 14±2 day dosing schedule during the maintenance phase (up to every
Bolnike s PNH, ki prejemajo zdravilo Soliris, je treba podobno nadzirati glede intravaskularne hemolize z merjenjem ravni LDH ter po potrebi prilagoditi odmerek v okviru priporočene sheme odmerjanja 14+/-2 dni med fazo vzdrževanja (največ vsakih 12 dni).
PNH patients were also treated with Soliris in a single arm 52 week study (C04-002), and in a long term extension study (E05-001).
Bolniki s PNH so bili z zdravilom Soliris zdravljeni tudi v okviru 52-tedenske študije z enim krakom (C04-002) ter v okviru dolgoročne podaljšane študije (E05-001).
Point estimate
ocena
Point estimate of the difference (Victrelis-RGT minus Victrelis- PR48)
Ocena razlike (Victrelis-RGT minus Victrelis-PR48)
point estimate was available for the remaining study.
Za preostale študije ocenjene vrednosti niso na voljo.
Point estimates [95 % CI] for the change from baseline to endpoint in YMRS using LOCF analysis in the two studies were as follows:
Točkovne ocene [95 % IZ] za spremembo od začetne vrednosti do končnega rezultata na lestvici manije po Young-u z uporabo LOCF analize v dveh študijah so bile sledeče:
Point pen up.
Peresnik usmerite navzgor.
Point the end of the nozzle slightly outwards, away from the centre ridge of your nose.
Usmerite konec nastavka rahlo navzven, proč od nosnega pretina.
Point the end of the nozzle slightly outwards, away from the centre ridge of your nose.
Usmerite konec šobe rahlo navzven, proč od osrednjega nosnega grebena.
Point the needle down into an empty container.
Usmerite iglo navzdol v prazen vsebnik.
Point the needle end straight up
Usmerite konec z iglo naravnost navzgor.
Point the needle of the pen up and away from you.
Iglo injekcijskega peresnika usmerite navzgor in stran od sebe.
Point the syringe into the mixing cup and slowly push the plunger to the correct mL for the dose (see Figure 10).
Usmerite brizgo v posodico za mešanje in počasi potisnite bat do pravilnega števila mililitrov za odmerek (glejte sliko 10).
Point the syringe tip up and remove any air bubbles by pointing the syringe tip up and gently tapping the syringe with your finger.
Konico brizge usmerite navzgor in odstranite morebitne zračne mehurčke tako, da konico brizge usmerite navzgor in s prsti narahlo potrkate po brizgi.
Point the tip of the oral dosing syringe towards either cheek.
Konico peroralne odmerne brizge usmerite v eno od lic.
Point-source approximation shows that the average dose rate experienced 20 hours after administration of a dose of 7.3 GBq EndolucinBeta labeled radiopharmaceutical (residual radioactivity 1.5 GBq) by a person at 1 meter distance from the patient’s body centre with an abdominal radius of 15 cm is 3.5 µSv/h.
Približek s točkovnim virom kaže, da pri osebi na razdalji enega metra od središča telesa bolnika s polmerom trebuha 15 cm, ki je pred 20 urami prejel odmerek 7,3 GBq radiofarmaka, označenega z radionuklidnim predhodnikom EndolucinBeta (preostala radioaktivnost 1,5 GBq), povprečna stopnja odmerka sevanja znaša 3,5 µSv/h.
Pointer
kazalnik
Pointer
notranji
Poisson regression
Poissonov a regresija
Poland/ Polska
Avstrija/Österreich
Polarisavenue 87
2132 JH Hoofddorp
Polio - a viral infection.
Otroška paraliza- virusna okužba.
Polio: a viral infection.
Otroška paraliza: je virusna okužba.
Poliomyelitis (often just called polio) is caused by viruses that affect the nerves.
Otroško paralizo (imenovano tudi poliomielitis) povzročajo virusi, ki prizadenejo živce.
Poliomyelitis (often just called polio): caused by viruses that affect the nerves.
Otroška paraliza (imenovana tudi poliomielitis): povzročajo jo virusi, ki prizadenejo živce.
poliomyelitis (polio, a disease that affects the nerves and can lead to muscle weakness or paralysis); invasive diseases (such as pneumonia and meningitis) caused by H. influenzae type-b bacteria (Hib).
otroško paralizo (boleznijo, ki prizadene živce in lahko povzroči oslabelost mišic ali paralizo); invazivnimi boleznimi (kot sta pljučnica in je meningitis), ki jih povzročajo bakterije H. influenzae tipa b (Hib).
polioviruses (types 1, 2 and 3) that have been inactivated (killed) so that they do not cause any disease.
poliovirusov (tipov 1, 2 in 3), ki so bili inaktivirani (uničeni), tako da ne povzročijo bolezni.
polioviruses (types 1, 2 and 3) that have been inactivated (killed) so they do not cause any disease; polysaccharides extracted from the ‘capsules’ that surround the Hib bacteria.
poliovirusov (tipov 1, 2 in 3), ki so bili inaktivirani (uničeni), tako da ne povzročijo bolezni; polisaharidov, pridobljenih iz „kapsul“, ki obkrožajo bakterije Hib.
Polishing agent: carnauba wax
Polirno sredstvo: karnauba vosek.
Polishing agent: carnauba wax.
Polirno sredstvo: karnauba vosek .
Polishing agent: carnauba wax.
Polirno sredstvo: karnauba vosek v oblogi tablete.
Polishing agent: carnauba wax.
Polirno sredstvo: karnauba vosek.
Pollakiuria
izpuščaj
Pollakiuria
polakisurija
Pollakiuria
polakiurija
Pollakiuria, micturition urgency, dysuria, nocturia, renal impairment, incontinence
polakisurija, urgentne mikcije, dizurija, nokturija, okvare ledvic, inkontinenca
Pollakiuria, nocturia Glycosuria, polyuria
Redki glikozurija, poliurija
pollakiuria, polyuria
polakiurija, poliurija
Poloxamer 188 Sucrose Methionine
poloksamer 188, saharoza metionin
Poloxamer 188, sucrose, methionine, disodium hydrogen phosphate dihydrate, sodium dihydrogen phosphate dihydrate, phosphoric acid and water for injections.
poloksamer 188, saharoza, metionin, dinatrijev hidrogenfosfat dihidrat, natrijev dihidrogenfosfat dihidrat, fosforjeva kislina in voda za injekcije.
Poly (DL-lactide-co-glycolide).
poli (DL-laktid-ko-glikolid)
Poly (vinyl alcohol), partially hydrolysed (E1203), titanium dioxide (E171), talc (E553b), lecithin (derived from soya bean (E322)), xanthan gum (E415), iron oxide red (E172).
Filmska obloga: delno hidroliziran polivinilalkohol (E1203), titanov dioksid (E171), smukec (E553b), lecitin (sojin (E322)), ksantanski gumi (E415), rdeči železov oksid (E172).
poly(butylmethacrylate, methylmethacrylate), acrylic copolymer.
polimer (butilmetakrilat, metilmetakrilat) akrilni kopolimer Adhezivni matriks zdravila:
Poly(dimethylsiloxane, trimethylsilyl silicate)-copolymerisate, Povidone K90, sodium metabisulphite (E223), ascorbyl palmitate (E304) and DL-α-tocopherol (E307).
poli(dimetilsiloksan, trimetilsililsilikat)-kopolimerizat, povidon K90, natrijev metabisulfit (E223), askorbilpalmitat (E304) in DL-α-tokoferol (E307).
Poly(vinyl alcohol) Talc
Obloga makrogol 3350 polivinil alkohol smukec
Poly(vinyl alcohol), Titanium dioxide (E171), Macrogol, Talc, Blue indigo carmine aluminium lake (E132)
Polivinilalkohol, titanov dioksid (E171), makrogol, smukec, indigotin (E132)
Polyamide/Al/PVC - Aluminium foil blister
Pretisni omot poliamid/Al/PVC – aluminijasta folija
Polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in patients from the age of 2 years
poliartritisa (pozitivnega ali negativnega za revmatoidni faktor) in razširjenega oligoartritisa pri bolnikih, starejših od 2 let.
Polyarticular juvenile idiopathic arthritis
poliartikularnega juvenilnega idiopatskega artritisa
Polyarticular juvenile idiopathic arthritis from 13 years of age
Poliartikularni juvenilni idiopatski artritis od 13. leta starosti.
Polyarticular juvenile idiopathic arthritis from 13 years of age
Poliartikularni juvenilni idiopatski artritis od 13.leta starosti
Polyarticular juvenile idiopathic arthritis from 2 to 12 years of age
Poliartikularni juvenilni idiopatski artritis od 2. do 12. leta starosti.
Polyarticular juvenile idiopathic arthritis from 2 to 12 years of age
Poliartikularni juvenilni idiopatski artritis od 2. do 12.leta starosti
Polyarticular juvenile idiopathic arthritis is an inflammatory disease that causes joint pain and swelling in children.
Poliartikularni juvenilni idiopatski artritis je vnetna bolezen, ki povzroča bolečine in otekanje sklepov pri otrocih.
Polycarbonate syringes must not be used with busulfan.
Pri uporabi busulfana ne smete uporabljati polikarbonatnih brizg.
Polychlorotrifluoroethylene (PCTFE)/PVC/Alu blister
pretisni omot iz poliklorotrifluoretilena (PCTFE)/PVC/Alu
Polychlorotrifluoroethylene (PCTFE)/PVC/Alu blister
pretisni omot iz poliklorotrifluoretilena (PCTFE)/PVC/Alu)
Polycythaemia (see Elevation of haemoglobin or haematocrit in section 4.4)
Policitemija (glejte Zvišanje ravni hemoglobina ali hematokrita v poglavju 4.4)
Polycythaemia vera
Prava policitemija
Polycythaemia vera (PV)
Prava policitemija
polydipsia, dehydration, hyperkalaemia, hyperglycaemia, decreased appetite
polidipsija, dehidracija, hiperkaliemija, hiperglikemija, zmanjšan apetit
Polyester and ethyl vinyl acetate
Adhezivni matriks zdravila:
polyester backing film printing ink containing Pigment White 6
zunanja prevleka iz poliestra tiskarsko črnilo s Pigment White 6
Polyethylene
polietilenska
Polyethylene
polietilenska plastenka
Polyethylene (HDPE) bottle of 20 ml (10 doses), 100 ml (50 doses) or 250 ml (125 doses) sealed with a rubber closure and secured with an aluminium cap.
Polietilenska (HDPE) plastenka s po 20 ml (10 odmerki), 100 ml (50 odmerki) ali 250 ml (125 odmerki) zaprta z gumijastim zamaškom in zavarovana z aluminijasto zaporko.
Polyethylene (PE)/Aluminium (Al)/ Polyethylene (PE) laminated plastic tubes with a high density polyethylene (HDPE) head and polypropylene (PP) child resistant closure.
S polietilenom (PE)/aluminijem (Al)/polietilenom (PE) laminirane plastične tube z glavo iz polietilena visoke gostote (HDPE) in za otroke varno zaporko iz polipropilena (PP).
Polyethylene (PE)/Aluminium (Al)/ Polyethylene (PE) laminated plastic tubes: EU/1/13/904/001
S polietilenom (PE)/aluminijem (Al)/polietilenom (PE) laminirane plastične tube: EU/1/13/904/001
Polyethylene (PE)/Copolymer/Aluminium (Al)/Copolymer/Polyethylene (PE) polyfoil plastic tubes (kind of laminate) with a high density polyethylene (HDPE) head and polyethylene (PE) child resistant closure
Plastične tube z večplastno folijo iz polietilena (PE)/kopolimera/aluminija (Al)/kopolimera/polietilena (PE) (vrsta laminata) z glavo iz polietilena visoke gostote (HDPE) in za otroke varno zaporko iz polietilena (PE).
Polyethylene (PE)/Copolymer/Aluminium (Al)/Copolymer/Polyethylene (PE) polyfoil plastic tubes (kind of laminate) with a high density polyethylene (HDPE) head and polypropylene (PP) child resistant closure.
Plastične tube z večplastno folijo iz polietilena (PE)/kopolimera/aluminija (Al)/kopolimera/polietilena (PE) (vrsta laminata) z glavo iz polietilena visoke gostote (HDPE) in za otroke varno zaporko iz polipropilena (PP).
Polyethylene (PE)/Copolymer/Aluminium (Al)/Copolymer/Polyethylene (PE) polyfoil plastic tubes: EU/1/13/904/004
Plastične tube z večplastno folijo iz polietilena (PE)/kopolimera/aluminija (Al)/kopolimera/polietilena (PE):
Polyethylene (PET) bottles with rubber stoppers and aluminium caps
plastenke iz PET plastike, zaprte z gumijastim zamaškom in aluminijasto zaporko.
Polyethylene bottle
polietilenska plastenka
Polyethylene bottle containing 10 ml, 15 ml or 30 ml with a polyethylene dropper and a tamper proof child resistant closure.
Polietilenska plastenka po 10 ml, 15 ml ali 30 ml s polietilensko kapalko in varnostnim, za otroke varnim zapiralom.
Polyethylene bottle containing 10 ml, 32 ml, 100 ml or 180 ml with a polyethylene dropper and a tamper proof child resistant closure.
Polietilenska plastenka po 10 ml, 32 ml, 100 ml ali 180 ml s polietilensko kapalko in varnostnim, za otroke varnim zapiralom.
Polyethylene bottle containing 15 ml or 30 ml with a polyethylene dropper and a tamper proof child resistant closure.
Polietilenska plastenka po 15 ml, ali 30 ml s polietilensko kapalko in varnostnim, za otroke varnim zapiralom.
Polyethylene bottle of 20 ml (10 doses), 100 ml (50 doses) or 250 ml (125 doses) sealed with a rubber closure and secured with an aluminium cap.
Polietilenska plastenka s po 20 ml (10 odmerki), 100 ml (50 odmerki) ali 250 ml (125 odmerki) zaprta z gumijastim zamaškom in zavarovana z aluminijasto zaporko.
Polyethylene bottle with a chlorobutyl elastomer closure and aluminium cap.
Polietilenska steklenica s klorobutilnim elastomernim zamaškom zaščitenim z aluminijasto kapico.
Polyethylene bottle with rubber closure and aluminium cap
Polietilenska steklenica z gumijastim zamaškom in aluminijasto zaporko
Polyethylene bottles containing a desiccant and closed with a polyethylene cap.
Polietilenske stekleničke, ki vsebujejo sušilo in so zaprte s polietilenskim pokrovčkom.
Polyethylene bottles with a chlorobutyl elastomer closure and aluminium cap.
Polietilenska steklenica s klorobutilnim elastomernim zamaškom zaščitenim z aluminijasto kapico.
polyethylene perfusion tubings with an inner diameter of 1 mm and a length of 150 cm polycarbonate infusion valves / Y connections polyurethane, polyurethane silicon coated catheters
polietilenskimi perfuzijskimi cevkami z notranjim premerom 1 mm in dolžino 150 cm polikarbonatnimi infuzijskimi ventili/Y-spoji katetri iz poliuretana s silikonsko oblogo ali brez
Polyethylene tablet container with CRC polypropylene cap.
Vsebnik iz polietilena z za otroke varno zaporko iz polipropilena.
Polyethylene terephthalate (PET) vials with rubber stopper and aluminium cap
viale iz polietilen tereftalata (PET) z gumijastimi zamaški in aluminijastimi zaporkami
Polyethylene terephthalate (PET) vials, with rubber stopper and aluminium cap
viale iz polietilen tereftalata (PET) z gumijastimi zamaški in aluminijastimi zaporkami
Polyethylene terephthalate bottle containing 10, 32, 100, 2 x 100 or 200 ml with two polyethylene/polypropylene measuring syringes.
Polietilen-tereftalat steklenička po 10 ml, 32 ml, 100 ml, 2 x 100 ml ali 200 ml s priloženima dvema polietilensko/polipropilenskima merilnima brizgalkama.
Polyethylene terephthalate bottle containing 15 or 30 ml with two polyethylene/polypropylene measuring syringes.
Polietilen-tereftalat steklenička po 15 ml in 30 ml s priloženima dvema polietilensko/polipropilenskima merilnima brizgalkama.
Polyethylene terephthalate bottle, HDPE/LDPE cap, polypropylene / polyethylene measuring syringe
Polietilen-tereftalat steklenička, z za otroke varnim zapiralom, polipropilenska/polietilenska merilna brizgalka
Polyethylene terephthalate bottle, HDPE/LDPE cap, polypropylene / polyethylene measuring syringe.
Polietilen-tereftalat steklenička, z za otroke varnim zapiralom, polipropilenska/polietilenska merilna brizgalka
Polyglucose-sorbitol carboxymethylether (PSC) Mannitol
poliglukoza-sorbitolkarboksimetileter manitol
polymyalgia rheumatica
revmatična polimialgija
polymyalgia rheumatica, arthritis
revmatična polimialgija, artritis
polymyalgia rheumatica, myositisd, arthritis, muscular weaknessd
revmatična polimialgija, miozitisd, artritis, mišična šibkostd
polymyositisd
polimiozitisd
polyneuropathy
polinevropatija
Polyolefin, PVC non-DEHP, or EVA intravenous tubing with a sterile, non-pyrogenic, low protein-binding 0.2 micrometre in-line filter.
Poliolefinski, ne-DEHP PVC ali EVA intravenski sistem s sterilnim, apirogenim 0,2 µm linijskim filtrom, ki minimalno veže beljakovine.
Polyolefin, PVC non-DEHP, or EVA intravenous tubing with a sterile, non-pyrogenic, low protein-binding 0.2 micrometre in-line filter;
Poliolefinski, ne-DEHP PVC ali EVA intravenski sistem s sterilnim, apirogenim 0,2 µm linijskim filtrom, ki malo veže beljakovine.
Polyomavirus
Poliomavirus
Polyoxyethylene oleic alcohol Potassium chloride,
Polioksietilen oleinski alkohol
polyoxyl 40 hydrogenated castor oil,
makrogolglicerol 40 hidrogenirano ricinusovo olje
Polyoxyl castor oil Citric acid (anhydrous) Ethanol
makrogolglicerol ricinolat citronska kislina (brezvodna) etanol
Polypropylene (PP) vials containing 50 ml, 250 ml and 500 ml of solvent closed with type I polymeric elastomer closures and aluminium caps.
Polipropilenske (PP) viale, ki vsebujejo 50 ml, 250 ml in 500 ml vehikla, zaprte z zamaškom iz polimernega elastomera tipa I in aluminijasto zaporko.
Polypropylene bags with butyl elastomer closure and trocar.
Polipropilenske vrečke z butilelastomernim pokrovčkom.
Polypropylene bottle Bottle of 10 or 25 doses
Polipropilenska steklenička Steklenička 10 ali 25 odmerki
Polypropylene bottle containing 3 ml with a polyethylene dropper and a tamper proof child resistant closure.
Polipropilenska plastenka po 3 ml s polietilensko kapalko in varnostnim, za otroke varnim zapiralom.
Polypropylene bottle of 50 or 100 ml with butyl elastomere closure Box of 1 bottle of 100 doses (1 x 100 ml)
50 ali 100 ml polipropilenska plastenka z butil elastomerno zaporko Škatla z 1 plastenko s 100 odmerki (1 x 100 ml).
Polypropylene bottle with a butyl elastomer closure and sealed with an aluminium cap.
Polipropilenska steklenička z butilelastomerno zaporko inzapečatena z aluminijastim pokrovčkom.
Polypropylene bottles of 20, 50 and 150 ml fitted with a low density polyethylene (LDPE) Press-In-bottle adapter and a child resistant closure.
Polietilenske plastenke po 20, 50 in 150 ml, zaščitene s pokrovčkom na pritisk iz polietilena nizke gostote (LDPE) in zaščito za otroke.
Polypropylene measuring syringe
Polipropilensko merilno brizgo
polypropylene polyethylene lined PVC polyurethane
polipropilena s polietilenom prevlečenega PVC poliuretana
Polypropylene tablet containers with tamper evident polyethylene closure containing 100 & 500 film- coated tablets per tablet container.
Vsebniki iz polipropilena z zaporko iz polietilena, ki omogoča evidentiranje odprtja, po 100 in 500 filmsko obloženih tablet v vsebniku.
Polypropylene tablet containers with tamper evident polyethylene closure containing 100 film-coated tablets per tablet container.
Vsebniki iz polipropilena z zaporko iz polietilena, ki omogoča evidentiranje odprtja, po 100 filmsko obloženih tablet v vsebniku.
Polypropylene tablet containers with tamper evident polyethylene closure containing 250 & 500 film- coated tablets per tablet container.
Vsebniki iz polipropilena z zaporko iz polietilena, ki omogoča evidentiranje odprtja, po 250 in 500 filmsko obloženih tablet v vsebniku.
Polypropylene tablet containers with tamper evident polyethylene closure containing 250 & 500 tablets per tablet container.
Vsebniki iz polipropilena z zaporko iz polietilena, ki omogoča evidentiranje odprtja, po 250 in 500 filmsko obloženih tablet v vsebniku.
Polypropylene vial of 100, 250 or 500 ml with a chlorobutyl rubber stopper and an aluminium cap.
Polipropilenska viala s, 100, 250 ali 500 ml, s klorobutilno gumijasto zaporko in aluminijastim pokrovčkom.
Polyproylene
Polipropilen
polyps)*
polipi)
Polyribosylribitol phosphate (PRP) from Haemophilus influenzae type b as PRP-OMPC 7.5 µg
Poliribozilribitolfosfat (PRP) Haemophilusa influenzae tipa b kot PRP - OMPC 7,5 µg OMPC (outer membrane protein complex - beljakovinski kompleks zunanje membrane)
Polysorbate 20 Water for injections
Polisorbat 20 Voda za injekcije
Polysorbate 80
polisorbat 80 sorbitan monooleat (E494)
Polysorbate 80 (E433) and phosal 50 PG (phosphatidylcholine, propylene glycol, mono-and diglycerides, ethanol, soya fatty acids, and ascorbyl palmitate).
Polisorbat 80 (E433) in phosal 50 PG (fosfatidilholin, propilenglikol, mono- in digliceridi, etanol, maščobne kisline iz soje in askorbilpalmitat).
Polysorbate 80 (Tween 80) 17 l
Polisorbat 80 (Tween 80) 17 μl
polysorbate 80 1.175 milligrams per 0.5 ml sorbitan trioleate 1.175 milligrams per 0.5 ml For a full list of excipients see section 6.1.
polisorbat 80 1,175 miligrama na 0,5 ml sorbitantrioleat 1,175 miligrama na 0,5 ml Za celoten seznam pomoţnih snovi glejte poglavje 6.1.
Polysorbate 80 Ethanol anhydrous Citric acid
polisorbat 80 brezvodni etanol citronska kislina
Polysorbate 80 Ethanol anhydrous Citric acid anhydrous
polisorbat 80 brezvodni etanol brezvodna citronska kislina
Polysorbate 80 Iron oxide yellow Iron oxide black
Polysorbát 80 Žltý oxid železitý
Polysorbate 80 Potassium Chloride
polisorbat 80 kalijev klorid
Polysorbate 80 Simethicone Sodium chloride Potassium chloride
Polisorbat 80 simetikon natrijev klorid kalijev klorid
Polysorbate 80 Sodium chloride
polisorbat 80 natrijev klorid
Polysorbate 80 Sorbitan oleate
polisorbat 80 sorbitan oleat
Polysorbate 80 Sucrose
13 (37,1%)
polysorbate 80 sunset yellow FCF (E110)
polisorbat 80 sončno rumeno FCF (E110)
Polysorbate 80 Water for injections
natrijev dihidrogenfosfat natrijev klorid polisorbat 80 voda za injekcije
Polysorbate 80, sodium chloride, sodium dihydrogen phosphate anhydrous, disodium phosphate anhydrous, hydrochloric acid concentrated, sodium hydroxide, water for injection.
polisorbat 80, natrijev klorid, brezvodni natrijev dihidrogenfosfat, brezvodni natrijev hidrogenfosfat, koncentrirana klorovodikova kislina, natrijev hidroksid, voda za injekcije.
Polysorbate 80f
polisorbat 80f
Polytrifluorochloroethylene, hexafluoropropene-vinyliden copolymer and polytetraflourethylene have been used extensively with pure nitric oxide and other corrosive gases.
S čistim dušikovim oksidom in drugimi jedkimi plini so pogosto uporabljali politrifluorokloroetilen, heksafluoropropen- viniliden kopolimer in politetrafluoretilen.
Polyuria Urine flow decreased
labši curek urina
polyvalent ions)
polivalentnimi ioni)
Polyvinyl alcohol
polivinilalkohol
Polyvinyl alcohol (E1203) Macrogol 3350 (E1520(iii)) Talc (E553b)
Filmska obloga: Polivinilalkohol (E1203) Makrogol 3350 (E1520(iii)) Smukec (E553b)
Polyvinyl alcohol (E1203) Macrogol 3350 (E1521) Titanium dioxide (E171) Talc (E553B)
Filmska obloga polivinilalkohol (E1203) makrogol 3350 (E1521) titanov dioksid (E171) smukec (E553B)